Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAB11FIP5 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | LBR | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | ZSCAN25 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ARG2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GSDMA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | PAXBP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PGS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | HACE1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SPRY2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | HMGXB4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |